Avipsa Bose

Avipsa Bose

Auto-generated profile, based on publicly available information

Avipsa Bose

Department of Developmental Biology and Genetics, Indian Institute of Science, Bengaluru, India

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
VMVishwas Mishra
Vishwas Mishra
ABAvipsa Bose
Avipsa Bose
SKShashi Kiran
Shashi Kiran
SBSanghita Banerjee
Sanghita Banerjee
ISIdrees A. Shah
Idrees A. Shah
SVSandhya S. Visweswariah
Sandhya S. Visweswariah
Activating mutations in receptor guanylyl cyclase C (GC-C), the target of gastrointestinal peptide hormones guanylin and uroguanylin, and bacterial heat-stable enterotoxins cause early-onset diarrhea and chronic inflammatory bowel disease (IBD). GC-C regulates ion and fluid secretion in the gut via cGMP production and activation of cGMP-dependent protein kinase II. We characterize a novel mouse model harboring an activating mutation in Gucy2c equivalent to that seen in an affected Norwegian family. Mutant mice demonstrated elevated intestinal cGMP levels and enhanced fecal water and sodium content. Basal and linaclotide-mediated small intestinal transit was higher in mutant mice, and they were more susceptible to DSS-induced colitis. Fecal microbiome and gene expression analyses of colonic tissue revealed dysbiosis, up-regulation of IFN-stimulated genes, and misregulation of genes associated with human IBD and animal models of colitis. This novel mouse model thus provides molecular insights into the multiple roles of intestinal epithelial cell cGMP, which culminate in dysbiosis and the induction of inflammation in the gut.

16 April 2024 in Journal of Biological Chemistry
Verified
Journal Article
Open access
ABArka Banerjee
Arka Banerjee
MCMoubani Chakraborty
Moubani Chakraborty
SSSuruchi Sharma
Suruchi Sharma
RCRuchi Chaturvedi
Ruchi Chaturvedi
ABAvipsa Bose
Avipsa Bose
SVSandhya S. Visweswariah
Sandhya S. Visweswariah
Mycobacterial genomes encode multiple adenylyl cyclases and cAMP effector proteins, underscoring the diverse ways these bacteria utilize cAMP. We identified universal stress proteins, Rv1636 and MSMEG_3811 in Mycobacterium tuberculosis and Mycobacterium smegmatis, respectively, as abundantly expressed, novel cAMP-binding proteins. Rv1636 is secreted via the SecA2 secretion system in M. tuberculosis but is not directly responsible for the efflux of cAMP from the cell. In slow-growing mycobacteria, intrabacterial concentrations of Rv1636 were equivalent to the concentrations of cAMP present in the cell. In contrast, levels of intrabacterial MSMEG_3811 in M. smegmatis were lower than that of cAMP and therefore, overexpression of Rv1636 increased levels of "bound" cAMP. While msmeg_3811 could be readily deleted from the genome of M. smegmatis, we found that the rv1636 gene is essential for the viability of M. tuberculosis and is dependent on the cAMP-binding ability of Rv1636. Therefore, Rv1636 may function to regulate cAMP signaling by direct sequestration of the second messenger. This is the first evidence of a "sponge" for any second messenger in bacterial signaling that would allow mycobacterial cells to regulate the available intrabacterial "free" pool of cAMP.

13 August 2025 in Biochemical Journal
Verified
Journal Article
Open access
ABAvipsa Bose
Avipsa Bose
SVSandhya S. Visweswariah
Sandhya S. Visweswariah
The important role that the gut plays in directing and modulating the well-being of the entire organism cannot be underestimated. We are beginning to dissect molecular players that are intrinsic to the functioning of the epithelial cells of the gut, which, in turn, control the responses of various tissues. In this review, we provide an overview of the role of a receptor guanylyl cyclase in regulating fluid–ion homeostasis, cell proliferation and the microbiome in the gut. Further elucidation of molecular details, aided by the development of novel mouse models and organoid cultures, should increase our understanding of the role of this receptor and cyclic guanosine 3′,5′-monophosphate in congenital secretory diarrhoea and inflammatory bowel disease.

23 January 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
ABArka Banerjee
Arka Banerjee
MCMoubani Chakraborty
Moubani Chakraborty
SSSuruchi Sharma
Suruchi Sharma
RCRuchi Chaturvedi
Ruchi Chaturvedi
ABAvipsa Bose
Avipsa Bose
SVSandhya S. Visweswariah
Sandhya S. Visweswariah
Mycobacterium tuberculosis employs several signaling pathways to regulate its cellular physiology and survival within the host. Mycobacterial genomes encode multiple adenylyl cyclases and cAMP effector proteins, underscoring the diverse ways in which these bacteria utilize cAMP. We have earlier identified universal stress proteins (USP), Rv1636 and MSMEG_3811 in M. tuberculosis and M. smegmatis respectively, as abundantly expressed, novel cAMP-binding proteins. In this study, we show that these USPs may function to regulate cAMP signaling by direct sequestration of the second messenger. In slow-growing mycobacteria, concentrations of Rv1636 were equivalent to the amounts of cAMP present in the cell, and overexpression of Rv1636 in M. smegmatis increased levels of ‘bound’ cAMP. Rv1636 is secreted via the SecA2 secretion system in M. tuberculosis but is not directly responsible for the efflux of cAMP from the cell. While msmeg_3811 could be readily deleted from the genome of M. smegmatis , we find that the rv1636 gene is essential for growth of M. tuberculosis , and this functionality depends on the cAMP-binding ability of Rv1636. This is the first evidence of a ‘sink’ for any second messenger in bacterial signaling that would allow mycobacterial cells to regulate the available intracellular ‘free’ pool of cAMP.

1 August 2026 in American Journal of Physiology-Gastrointestinal and Liver Physiology
Verified
Journal Article
Closed access
ABAvipsa Bose
Avipsa Bose
YBYashika Bopanna
Yashika Bopanna
PSPallavi Shetty
Pallavi Shetty
KSKritica Sharma
Kritica Sharma
JMJohn Kandam Kulathu Mathew
John Kandam Kulathu Mathew
SVSandhya S. Visweswariah
Sandhya S. Visweswariah
Activating mutations in GUCY2C, which encodes the receptor guanylyl cyclase C (GC-C), cause early-onset diarrheal disease and gastrointestinal inflammation. Knock-in mice carrying a familial diarrheal syndrome mutation exhibited impaired gut barrier function. Mutant organoids showed defective secretory lineage specification associated with reduced Wnt3 expression. Zinc administration, which lowers epithelial cGMP levels by inhibiting GC-C, reversed most pathological changes in both mice and organoids.

27 October 2026 in Insights in Biochemistry and Molecular Biology
Verified
Journal Article
Open access
APArathi B. Prabhashankar
Arathi B. Prabhashankar
ATAnkit K. Tamta
Ankit K. Tamta
NANinitha Asirvatham-Jeyaraj
Ninitha Asirvatham-Jeyaraj
VRVenketsubbu Ramasubbu
Venketsubbu Ramasubbu
BSBhoomika Shivanaiah
Bhoomika Shivanaiah
NSNagalingam R. Sundaresan
Nagalingam R. Sundaresan